Search Within

Sean McCarthy Devlin

  1. "2020"
Formats
  1. Meeting Abstract (32)
  2. Journal Article (19)
  3. Research Letter (4)
  4. Correspondence (1)
Groups
  1. Biostatistics Service (56)
  2. Epidemiology and Biostatistics (56)
  3. Center for Hematologic Malignancies (55)
  4. Department of Medicine (55)
  5. Hematologic Malignancies, Division of (55)
  6. Bone Marrow Transplant (45)

More Groups

People
  1. Sergio Giralt (39)
  2. Miguel-Angel Perales (33)
  3. Gunjan Shah (31)
  4. Michael Scordo (31)
  5. Molly Maloy (27)
  6. Parastoo Dahi (25)

More People

Years
  1. 2020 (56)
Publications
  1. Biology of Blood and Marrow Transplantation (19)
  2. Blood (11)
  3. Bone Marrow Transplantation (8)
  4. Blood Advances (5)
  5. Leukemia and Lymphoma (2)
  6. Blood Cancer Journal (1)

More Publications

Publishers
  1. Elsevier Inc. (19)
  2. American Society of Hematology (16)
  3. Nature Publishing Group (12)
  4. Taylor & Francis Group (2)
  5. American Association for Cancer Research (1)
  6. American Society for Clinical Investigation (1)

More Publishers

Results (56)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • A pilot study evaluating lenalidomide and CC-486 in combination with radiotherapy for patients with plasmacytoma (LENAZART study)
    Meeting Abstract

    Shah, U. A.; Werner, K.; Tavitian, E.; Devlin, S.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Tan, C.; Lu, S. X.; Smith, E. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Secondary graft-versus-host disease (GVHD) prophylaxis with oral proteasome inhibitor ixazomib is associated with low incidence of recurrent, late acute and chronic GVHD and facilitated calcineurin inhibitor taper within the first year post allogeneic stem cell transplantation
    Meeting Abstract

    Rodriguez, N.; Lee, J.; Flynn, L.; Murray, F.; Devlin, S.; Izquierdo, C. S.; Cho, C.; Dahi, P. B.; Giralt, S. A.; Sauter, C. S.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Machine learning for prediction of cancer-associated venous thromboembolism
    Meeting Abstract

    Mantha, S.; Dunbar, A.; Bolton, K. L.; Devlin, S.; Gorenshteyn, D.; Donoghue, M.; Arcila, M. E.; Soff, G. A.
    Blood (2020)

    Fulltext@MSK | Save
  • Rabbit anti-thymocyte globulin exposure (rATG) in CD34+ selected hematopoietic cell transplantation and its impact on immune reconstitution and outcomes in children and adults
    Meeting Abstract

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jakubowski, A. A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Association of patient activity bioprofiles with Hrqol and clinical responses: A prospective novel trial using mobile wearables in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Korde, N.; Tavitian, E.; Derkach, A.; Zarski, A.; Salcedo, M.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; Smith, E. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical impact of bridging therapy prior to commercial chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory lymphomas
    Meeting Abstract

    Imber, B. S.; Perales, M. A.; Flynn, J.; Ruiz, J. D.; Devlin, S.; Alarcon Tomas, A.; Hajj, C.; Batlevi, C. L.; Dahi, P. B.; Lin, R. J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis
    Meeting Abstract

    Gao, T.; Ptashkin, R.; Bolton, K. L.; Fong, C.; Spitzer, B.; Menghrajani, K.; Arango Ossa, J. E.; Zhou, Y.; Bernard, E.; Levine, M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Long-term sustained minimal residual disease (MRD) negativity in patients with multiple myeloma treated with continuous lenalidomide maintenance therapy: A clinical and correlative phase 2 study
    Meeting Abstract

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clonal hematopoiesis and COVID-19 severity in cancer patients
    Meeting Abstract

    Bolton, K. L.; Foote, M.; Jee, J.; Safonov, A.; Ptashkin, R.; Devlin, S.; Gedvilaite, E.; Gao, T.; Papaemmanuil, E.; Pessin, M. S.; more...
    Blood (2020)

    Fulltext@MSK | Save